BioSpace News Archive

Drug Development

Audentes Therapeutics Presents New Positive Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 for X-linked Myotubular Myopathy, at 22nd Annual Meeting of the American Society of Gene and Cell Therapy

New data include 48 weeks of follow-up for six treated patients in dose Cohort 1 and 24 weeks for three treated patients in dose Cohort 2

May 1, 2019
·
8 min read
BioMidwest

FAST BioMedical enrolls 20th patient in German Heart Failure Trial

FAST BioMedical has enrolled 20 patients in a clinical trial at Charité – Universitätsmedizin Berlin.

May 1, 2019
·
2 min read
Deals

Sangamo Therapeutics Announces First Quarter 2019 Conference Call And Webcast

Sangamo Therapeutics, Inc. announced that the Company will release its first quarter 2019 financial results after the market closes on Wednesday, May 8, 2019.

May 1, 2019
·
1 min read
Deals

Dexcom Reports First Quarter 2019 Financial Results

DexCom, Inc. reported its financial results as of and for the quarter ended March 31, 2019.

May 1, 2019
·
6 min read
Business

STAAR Surgical Reports First Quarter Results

STAAR Surgical Company reported financial results for the first quarter ended March 29, 2019.

May 1, 2019
·
8 min read
Biotech Bay

Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System

Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments

May 1, 2019
·
5 min read
Drug Development

Exelixis Initiating Phase 3 Pivotal Trial (COSMIC-313) of Cabozantinib in Combination with Nivolumab and Ipilimumab Versus Nivolumab and Ipilimumab in Previously Untreated Advanced Renal Cell Carcinoma

COSMIC-313 is the third phase 3 pivotal trial to investigate cabozantinib in combination with immune checkpoint inhibitors

May 1, 2019
·
13 min read
Deals

Illumina to Webcast Upcoming Investor Conference Presentation - May 1, 2019

Illumina, Inc. announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

May 1, 2019
·
1 min read
Deals

Anka Behavioral Health, Inc. Announces Wind Down of Residential Treatment Programs as Company Enters Chapter 11

Anka Behavioral Health, Inc. announced that it has begun the orderly wind down of all of its residential treatment programs and has initiated proceedings under chapter 11 of the United States Bankruptcy Code in the Northern District of California.

May 1, 2019
·
2 min read
Policy

Canada now has the best tobacco plain packaging regulations in the world

Canadian Cancer Society says new regulations will save lives

May 1, 2019
·
3 min read